Big data, big consortia, and pain: UK Biobank, PAINSTORM, and DOLORisk

Harry L Hébert1, Mathilde M V Pascal2, Blair H Smith1

  • 1Chronic Pain Research Group, Division of Population Health and Genomics, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom.

Pain Reports
|January 16, 2024
PubMed

Insights

Large consortia and biorepositories are crucial for chronic pain (CP) research. Standardized phenotyping in large cohorts enhances study power for understanding CP risk factors and pathogenesis.

Area of Science:

  • Pain Medicine
  • Genetics
  • Epidemiology

Background:

  • Chronic pain (CP) is a prevalent, debilitating condition with significant socioeconomic consequences.
  • Managing refractory CP and understanding its heterogeneous nature, including neuropathic pain, presents challenges due to limited research data.
  • Existing studies are hampered by inconsistent phenotyping, data collection, and small sample sizes, limiting analytical power, especially for genome-wide association studies.

Purpose of the Study:

  • To review the approach used in the DOLORisk study for investigating neuropathic pain.
  • To explain how DOLORisk has informed ongoing projects like PAINSTORM and UK Biobank rephenotyping.
  • To provide an overview of study outputs and lessons learned for future chronic pain research endeavors.

Main Methods:

  • Formation of large research consortia (e.g., DOLORisk, PAINSTORM) and utilization of biorepositories (e.g., UK Biobank).
  • Implementation of a common approach for CP phenotyping to enable data harmonization across cohorts.
  • Leveraging large-scale data to increase statistical power for genetic and etiological studies of CP.

Main Results:

  • The development of standardized phenotyping protocols has facilitated data harmonization.
  • Increased study power through large consortia and biorepositories enables more robust analyses of CP risk factors and pathogenesis.
  • Outputs from DOLORisk and related projects provide insights into neuropathic pain and inform future research strategies.

Conclusions:

  • Large-scale, harmonized data collection through consortia and biorepositories is essential for advancing chronic pain research.
  • Standardized phenotyping is key to overcoming previous limitations in CP studies, particularly for understanding genetic and environmental risk factors.
  • Future research should build upon these collaborative models to enhance understanding and management of chronic pain, including neuropathic pain.